These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25321168)

  • 1. The gap between endothelial cells: key to the quick escape of nanomaterials?
    Setyawati MI; Tay CY; Leong DT
    Nanomedicine (Lond); 2014 Aug; 9(11):1591-4. PubMed ID: 25321168
    [No Abstract]   [Full Text] [Related]  

  • 2. [Targeted nanomedicine in diagnostics and therapy of neurological diseases].
    Bertalan F; László B; Attila V
    Ideggyogy Sz; 2013 May; 66(5-6):155-63. PubMed ID: 23909015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A facile approach for the delivery of inorganic nanoparticles into the brain by passing through the blood-brain barrier (BBB).
    Yim YS; Choi JS; Kim GT; Kim CH; Shin TH; Kim DG; Cheon J
    Chem Commun (Camb); 2012 Jan; 48(1):61-3. PubMed ID: 22057099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming the Blood-Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases.
    Furtado D; Björnmalm M; Ayton S; Bush AI; Kempe K; Caruso F
    Adv Mater; 2018 Nov; 30(46):e1801362. PubMed ID: 30066406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomaterials for enhanced immunity as an innovative paradigm in nanomedicine.
    Seth A; Oh DB; Lim YT
    Nanomedicine (Lond); 2015; 10(6):959-75. PubMed ID: 25867860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood-brain barrier.
    Lu W; Tan YZ; Hu KL; Jiang XG
    Int J Pharm; 2005 May; 295(1-2):247-60. PubMed ID: 15848009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biocompatibility and nanostructured materials: applications in nanomedicine.
    Adabi M; Naghibzadeh M; Adabi M; Zarrinfard MA; Esnaashari SS; Seifalian AM; Faridi-Majidi R; Tanimowo Aiyelabegan H; Ghanbari H
    Artif Cells Nanomed Biotechnol; 2017 Jun; 45(4):833-842. PubMed ID: 27247194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanodiamonds for nanomedicine.
    Xing Y; Dai L
    Nanomedicine (Lond); 2009 Feb; 4(2):207-18. PubMed ID: 19193186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro assessment of alkylglyceryl-functionalized chitosan nanoparticles as permeating vectors for the blood-brain barrier.
    Lien CF; Molnár E; Toman P; Tsibouklis J; Pilkington GJ; Górecki DC; Barbu E
    Biomacromolecules; 2012 Apr; 13(4):1067-73. PubMed ID: 22409486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similar molecular descriptors determine the in vitro drug permeability in endothelial and epithelial cells.
    Hakkarainen JJ; Pajander J; Laitinen R; Suhonen M; Forsberg MM
    Int J Pharm; 2012 Oct; 436(1-2):426-43. PubMed ID: 22750947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotechnology for neurodegenerative disorders.
    Re F; Gregori M; Masserini M
    Nanomedicine; 2012 Sep; 8 Suppl 1():S51-8. PubMed ID: 22640910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer nanomedicine and tumor vascular permeability; Where is the missing link?
    Taurin S; Nehoff H; Greish K
    J Control Release; 2012 Dec; 164(3):265-75. PubMed ID: 22800576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electromagnetic interference in the permeability of saquinavir across the blood-brain barrier using nanoparticulate carriers.
    Kuo YC; Kuo CY
    Int J Pharm; 2008 Mar; 351(1-2):271-81. PubMed ID: 17976933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of coculture model of blood-brain barrier in vitro for nanoparticle's transcytosis and toxicity evaluation.
    Lu W; Tan YZ; Jiang XG
    Yao Xue Xue Bao; 2006 Apr; 41(4):296-304. PubMed ID: 16856472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.
    Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M
    Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Internal benchmarking of a human blood-brain barrier cell model for screening of nanoparticle uptake and transcytosis.
    Ragnaill MN; Brown M; Ye D; Bramini M; Callanan S; Lynch I; Dawson KA
    Eur J Pharm Biopharm; 2011 Apr; 77(3):360-7. PubMed ID: 21236340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental tools to monitor the dynamics of endothelial barrier function: a survey of in vitro approaches.
    Wegener J; Seebach J
    Cell Tissue Res; 2014 Mar; 355(3):485-514. PubMed ID: 24585359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial nanomedicine.
    Yacoby I; Benhar I
    Nanomedicine (Lond); 2008 Jun; 3(3):329-41. PubMed ID: 18510428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Polysorbate-80 modified neurotoxin nanoparticle with its transport and cytotoxicity against blood-brain barrier].
    Zhao YM; Xia AX; Wei YH; Ruan YP; Li FZ
    Yao Xue Xue Bao; 2010 Oct; 45(10):1312-6. PubMed ID: 21348312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remote Control of Cellular Functions: The Role of Smart Nanomaterials in the Medicine of the Future.
    Genchi GG; Marino A; Grillone A; Pezzini I; Ciofani G
    Adv Healthc Mater; 2017 May; 6(9):. PubMed ID: 28338285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.